Literature DB >> 9657011

Nonfunctioning islet cell tumors of the pancreas: clinical, imaging and pathological aspects in 16 patients.

H Furukawa1, K Mukai, T Kosuge, Y Kanai, K Shimada, J Yamamoto, Y Mizuguchi, K Ushio.   

Abstract

BACKGROUND: Nonfunctioning islet cell tumors (NFICTs) usually reach a large size prior to detection, at which stage patients have some symptoms or signs. Recently, NFICTs have been discovered in asymptomatic patients with increasing frequency owing to advances in diagnostic imaging techniques. This study investigated clinical, imaging and pathological features in recent cases of NFICT.
METHODS: The medical records, radiographs and pathological specimens of 16 patients with NFICT who were evaluated between April 1991 and March 1996 were reviewed.
RESULTS: Tumor sizes ranged from 0.8 to 17 cm (average, 5.2 cm). Five patients (31%) had some symptoms or signs at the time of diagnosis; however, the other 11 (69%) had no symptoms. Of 10 patients with a tumor of size 5 cm or less, nine were asymptomatic and all tumors were histologically benign. In contrast, in six patients with a tumor larger than 5 cm, four had some symptoms and five tumors were malignant. The detection rates of pancreatic tumor mass on ultrasonography and computed tomography were 94% (15/16) each. All 14 patients in whom the tumor was completely resected survived without recurrence; however, the remaining two patients with liver metastases died following recurrence.
CONCLUSIONS: US and CT are useful in detecting NFICTs even if the tumor is small and the patient is asymptomatic. The detection of NFICTs of small size and their complete removal are essential for a successful cure.

Entities:  

Mesh:

Year:  1998        PMID: 9657011     DOI: 10.1093/jjco/28.4.255

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  8 in total

1.  Management of a patient diagnosed with pancreatic cancer and myelodysplastic syndrome.

Authors:  Elizabeth Won; Kenneth H Yu; Ali Shamseddine; Leonard Saltz; Deborah Mukherjee; Ali Haydar; Ashwaq El-Olayan; Sally Temraz; Mohamed Naghy; Dorothy Makanjoula; Eileen M O'Reilly; Ghassan K Abou-Alfa
Journal:  Gastrointest Cancer Res       Date:  2013-03

2.  Retrospective Review of Cross Sectional Imaging Findings of Pancreatic Non-functional Islet Cell Tumor (NFICT) and its Hepatic Metastases.

Authors:  Rashid Al Sukaiti; Kathryn Robinson; Christine Menias
Journal:  Oman Med J       Date:  2011-01

Review 3.  A case of mixed acinar-endocrine carcinoma of the pancreas discovered in an asymptomatic subject.

Authors:  T Ogawa; S Isaji; T Yabana
Journal:  Int J Pancreatol       Date:  2000-06

Review 4.  Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors.

Authors:  Thorvardur R Halfdanarson; Joseph Rubin; Michael B Farnell; Clive S Grant; Gloria M Petersen
Journal:  Endocr Relat Cancer       Date:  2008-06       Impact factor: 5.678

5.  Management of nonfunctioning islet cell tumors.

Authors:  Han Liang; Pu Wang; Xiao-Na Wang; Jia-Cang Wang; Xi-Shan Hao
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

6.  Prognostic Significance of p27, Ki-67, and Topoisomerase lla Expression in Clinically Nonfunctioning Pancreatic Endocrine Tumors.

Authors:  Hee Jin Chang; Kenneth P. Batts; Ricardo V. Lloyd; Thomas J. Sebo; Geoffrey B. Thompson; Christine M. Lohse; Shane V. Pankratz
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

7.  Pancreatic Neuroendocrine Tumor with Atypical Radiologic Presentation.

Authors:  Ramandeep Singh; Sean Calhoun; Minchul Shin; Robert Katz
Journal:  Radiol Case Rep       Date:  2015-11-06

Review 8.  Imaging presentation of pancreatic neuroendocrine neoplasms.

Authors:  Valentina Ciaravino; Riccardo De Robertis; Paolo Tinazzi Martini; Nicolò Cardobi; Sara Cingarlini; Antonio Amodio; Luca Landoni; Paola Capelli; Mirko D'Onofrio
Journal:  Insights Imaging       Date:  2018-10-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.